Quantcast
Last updated on April 17, 2014 at 17:30 EDT

Latest Ventricular assist device Stories

2011-09-19 15:00:00

FRAMINGHAM, Mass. and SYDNEY, Sept. 19, 2011 /PRNewswire/ -- HeartWare International, Inc. (NASDAQ: HTWR - ASX: HIN), a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure, today announced that CEO Doug Godshall is scheduled to present at the Lazard Capital Markets 3rd Annual Circulatory Assist Device Day at 1:55 p.m. ET on Thursday, September 22, 2011. The one-day conference is being held at...

2011-09-18 07:00:00

BOSTON, Sept. 18, 2011 /PRNewswire/ -- The 15th Annual Scientific Meeting of the Heart Failure Society of America (HFSA) will include a presentation by Dr. Michael Petty, RN, PhD, on the issues surrounding caregivers of heart failure patients supported with left ventricular assist devices (LVADs), entitled "Family Caregivers: Supporting the Support System." In his presentation, Dr. Petty will discuss the problems faced by the 52 million Americans who provide unpaid care to adult family...

2011-09-14 15:00:00

FRAMINGHAM, Mass. and SYDNEY, Sept. 14, 2011 /PRNewswire/ -- HeartWare International, Inc. (NASDAQ: HTWR - ASX: HIN), a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure, today announced that CEO Doug Godshall is scheduled to present at the UBS Global Life Sciences Conference at 10:30 a.m. ET on Wednesday, September 21, 2011. The conference is being held September 19-21, 2011 at the Grand Hyatt...

2011-09-09 07:45:00

LOUISVILLE, Ky., Sept. 9, 2011 /PRNewswire/ -- Data presented today at the 19th Congress of the International Society for Rotary Blood Pumps (ISRBP) demonstrated that the HeartWare MVAD(®) Pump attained the objectives for system performance, hemocompatability and biocompatibility in Good Laboratory Practice (GLP) animal studies, a significant step prior to commencement of human clinical studies. (Photo: http://photos.prnewswire.com/prnh/20110909/LA65433) HeartWare's...

2011-09-06 07:30:00

PLEASANTON, Calif., Sept. 6, 2011 /PRNewswire/ -- Thoratec Corporation (NASDAQ: THOR), a world leader in device-based mechanical circulatory support therapies to save, support and restore failing hearts, said today it will be participating in three upcoming investor conferences. On Thursday, September 8, the company will participate in the Robert W. Baird & Co. 2011 Health Care Conference. Taylor Harris, Senior Director of Investor Relations and Business Development, will provide an...

2011-08-31 10:00:00

HOUSTON, Aug. 31, 2011 /PRNewswire/ -- Texas Children's Hospital in Houston, the first pediatric hospital in the world to implant the only approved Total Artificial Heart into the chest of a teen, is now sending the patient home. Jordan Merecka, 18, will be using the Freedom® portable driver, a wearable power supply that can be carried in a backpack and run his Total Artificial Heart while he waits for a donor heart. To view a video of Jordan and his new backpack, see:...

2011-08-12 11:44:00

FRAMINGHAM, Mass and SYDNEY, Aug. 12, 2011 /PRNewswire/ -- HeartWare International, Inc. (NASDAQ: HTWR; ASX: HIN), a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure, today announced that CEO Doug Godshall is scheduled to make an investor presentation at the Wedbush Securities 2011 Life Sciences Management Access Conference at 9:10 a.m. Eastern Time on Wednesday, August 17, 2011. The...

2011-08-08 11:29:00

FRAMINGHAM, Mass. and SYDNEY, Aug. 8, 2011 /PRNewswire/ -- HeartWare International, Inc. (NASDAQ: HTWR; ASX: HIN), a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure, today announced that CEO Doug Godshall is scheduled to make an investor presentation at the Canaccord Genuity 31st Annual Growth Conference at 9:00 a.m. U.S. Eastern Time on Thursday, August 11, 2011. The conference is being...

2011-08-04 16:56:07

Surgeons at the University of Kentucky on Aug. 3 announced that they were among the first to use artificial-lung technology to demonstrate the feasibility of a lung transplant, using a device invented by two university faculty members, Dr. Joseph Zwischenberger and Dr. Dongfang Wang. "The device helps patients get oxygen into their blood by transporting blood to a gas exchanger that removes carbon dioxide and oxygenates the blood before returning it to the heart, bypassing the lungs of the...

2011-08-03 15:02:00

PLEASANTON, Calif., Aug. 3, 2011 /PRNewswire/ -- Thoratec Corporation (Nasdaq: THOR), a world leader in device-based mechanical circulatory support therapies to save, support and restore failing hearts, announced today that it has acquired the medical business of Levitronix LLC ("Levitronix Medical") for an upfront cash payment of $110 million, as well as potential future cash earnout payments of up to $40 million. This transaction solidifies Thoratec's position as the leading, full-line...


Latest Ventricular assist device Reference Libraries

0_886104d1c1c698f3a531e056704457d5
2010-10-14 16:46:25

The artificial heart, a mechanical heart replacement, is typically used in order to bridge the time to heart transplant or to replace the heart in case a transplant is impossible. Often ventricular assist devices are confused with mechanical hearts because the assist the heart through pumps. They are also different from a cardiopulmonary bypass machine which is an external device used to provide the function of the heart and lungs. CPBs are usually only used for a few hours at a time,...

More Articles (1 articles) »